A Study to Evaluate the Efficacy and Safety of Gantenerumab in Participants at Risk for or at the Earliest Stages of Alzheimer's Disease (AD)
Clinical trial NCT05256134 · TERMINATED
Trial details
- NCT number
- NCT05256134
- Sponsor
- Hoffmann-La Roche
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-19
- Primary completion
- 2023-03-13
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.